- Home
- / Dianthus Therapeutics
Dianthus Therapeutics
Total Funding
$136.5 M
Dianthus Therapeutics Summary
Company Summary
- Overview
- Dianthus Therapeutics is a biotech company developing therapeutics and drugs to treat severe and rare autoimmune diseases. It designs and delivers monoclonal antibodies to allow people with rare and severe autoimmune diseases live healthier lives.
- Type
- Private
- Status
- Active
- Founded
- 2019
- HQ
- Waltham, MA, US | view all locations
- Website
- https://dianthustx.com/
- Cybersecurity rating
Table of Contents
Key People
Evan Thompson, Chief Operating Officer
Edward Carr, Chief Accounting Officer
Simrat Randhawa, Chief Medical Officer
LocationsView all
2 locations detected
Waltham, MA HQ
United States
203 Crescent St 17 102b
New York, NY
United States